Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06744907 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
A Phase 4 study of Spinal Fusion, sponsored by Akron Children's Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06744907 is a Phase 4 study of Spinal Fusion that is actively recruiting participants, run by Akron Children's Hospital. The registered enrollment target is 60 participants, below the 480-participant average among 19 other Spinal Fusion trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06744907, a Phase 4 study of Spinal Fusion, is actively recruiting participants, sponsored by Akron Children's Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
Conditions Studied
Interventions
- BIOLOGICAL 10% Povidone-Iodine Arm
- PROCEDURE Saline Arm
Study Locations (1)
Ohio
- Akron Children's Hospital - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-01-03 |
| Est. Completion | 2026-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06744907
The ClinicalTrials.gov registry entry for NCT06744907 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 480-participant average among 19 other Spinal Fusion trials with a reported enrollment target (87% lower). The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which 10% Povidone-Iodine Arm is the first listed.
NCT06744907 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06744907 about?
NCT06744907 is a clinical study titled "Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion". Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
What is the current status of trial NCT06744907?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2025-01-03. Estimated completion is 2026-11.
What conditions does trial NCT06744907 study?
This clinical trial studies the following conditions: Spinal Fusion.
What interventions are being tested in trial NCT06744907?
The interventions under investigation include: 10% Povidone-Iodine Arm (BIOLOGICAL), Saline Arm (PROCEDURE).
Who is sponsoring clinical trial NCT06744907?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06744907 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.